Baker Bros. Advisors LP Frequency Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $386,662 - $513,883	-55,555 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.99 - $55.01 $6.4 Million - $44.1 Million	-800,952 Reduced 93.51%	55,555 $528,000
Q4 2020 Feb 16, 2021	SELL	$18.65 - $40.0 $1.74 Million - $3.72 Million	-93,048 Reduced 9.8%	856,507 $30.2 Million
Q3 2020 Nov 16, 2020	BUY	$17.76 - $24.96 $68,127 - $95,746	3,836 Added 0.41%	949,555 $18.2 Million
Q2 2020 Aug 14, 2020	SELL	$14.65 - $24.9 $3.43 Million - $5.84 Million	-234,443 Reduced 19.87%	945,719 $22 Million
Q1 2020 May 15, 2020	SELL	$16.36 - $27.55 $838,793 - $1.41 Million	-51,271 Reduced 4.16%	1,180,162 $21 Million
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $15.6 Million - $23.1 Million	1,231,433 New	1,231,433 $21.6 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.